Oxantel

This classification denotes a pyrantel analog and antinematodal agent with the molecular formula C13H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94AJJ30D9E, chemically known as phenol, 3-(2-(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)ethenyl)-, (e)- but generally known as oxantel, which bears US NIH Compound Identifier 5281087. European Medicines Agency schedules Oxantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09497MIG. World Health Organization schedules oxantel in its Anatomical Therapeutic Chemical (ATC) Classification. OXANTEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxantel under HS 29335995 and SITC 51576. As of Q4 2014, OXANTEL remains the US FDA Preferred Term for this commodity. Oxantel bears US NLM identifiers UMLS ID C0069734 and NCI Concept Code C96694. SMILES: OC1CC(/C=C/C2=NCCCN2C)CCC1.